PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Thürmann, L.* ; Bauer, M.* ; Ferland, M. ; Messingschlager, M.* ; Schikowski, T.* ; von Berg, A.* ; Heinrich, J. ; Herberth, G.* ; Lehmann, I.* ; Standl, M. ; Trump, S.*

Undiagnosed pediatric elevated blood pressure is characterized by induction of pro-inflammatory and cytotoxic mediators.

Hypertension 80, 2425-2436 (2023)
Verlagsversion DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
BACKGROUND: Inflammatory processes have been suggested as a culprit of vascular damage in pediatric hypertension. We aimed to investigate transcriptional changes of immune modulators and determine their association with office blood pressure in adolescents who were not diagnosed with hypertension at the time of the study visit. METHODS: Office blood pressure measurements and blood samples were taken from adolescents of 2 German birth cohorts, GINIplus (The German Infant Study on the Influence of Nutrition Intervention Plus Air Pollution and Genetics on Allergy Development; discovery cohort, n=1219) and LISA (Influences of Lifestyle-related factors on the Immune System and the Development of Allergies in Childhood; validation cohort, n=809), during the 15-year follow-up visit and categorized based on the European Society of Hypertension Guideline. Hs-CRP (high-sensitivity C-reactive protein) and expression of 51 genes encoding cytokines/receptors and transcription factors were analyzed. RESULTS: The prevalence of elevated systolic blood pressure (overweight/obese) was 14.0% (5.1%) and 16.4% (5.2%) in the discovery and validation cohorts, respectively. An enhanced cytotoxic (GZMB, PRF1, IL2RB) and proinflammatory (FOS, IL1B, hs-CRP) immune profile was observed in association with the hypertension class in both cohorts. Expression of hs-CRP and IL1B was driven by overweight with IL1B being identified as a mediator between body mass index and elevated systolic blood pressure (adj.β/95% CI, 0.01/0.0002-0.02). The association of GZMB (adjusted odds ratio/95% CI, 1.67/1.26-2.21; P=0.0004) and PRF1 (adjusted odds ratio/95% CI, 1.70/1.26-2.29; P=0.0005) in the hypertension class remained significant in normal-weight individuals without parental predisposition. These effects were confirmed in LISA. CONCLUSIONS: Adolescent hypertension is not limited to known risk groups. As adolescents in the hypertension class show an inflammatory profile similar to that of established hypertension in adults, blood pressure monitoring at a young age is critical to ensure early intervention and prevention of adverse sequelae.
Impact Factor
Scopus SNIP
Altmetric
8.300
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Child ; Cytokines ; Gene Expression ; Hypertension ; Immune System ; Overweight ; Risk Factor; Cd8(+) T-cells; Risk-factors; C-fos; Hypertension; Infiltration; Metabolism; Activation; Expression; Guidelines; Adults
Sprache englisch
Veröffentlichungsjahr 2023
HGF-Berichtsjahr 2023
ISSN (print) / ISBN 0194-911x
e-ISSN 1524-4563
Zeitschrift Hypertension
Quellenangaben Band: 80, Heft: 11, Seiten: 2425-2436 Artikelnummer: , Supplement: ,
Verlag Lippincott Williams & Wilkins
Verlagsort Two Commerce Sq, 2001 Market St, Philadelphia, Pa 19103 Usa
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Epidemiology (EPI)
POF Topic(s) 30202 - Environmental Health
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-504000-008
Förderungen Commission of the European Communities, the seventh Framework Program: MeDALL project
Federal Ministry for Environment (IUF)
center (Helmholtz-Zentrum fuer Umweltforschung, Pediatric Practice, Bad Honnef)
center (Technische Universitaet Munich)
center (LMU Munich)
center (Research Institute at Marien-Hospital Wesel/Evangelisches Krankenhaus Duesseldorf)
center (Helmholtz Zentrum Muenchen - Deutsches Forschungszentrum fuer Gesundheit und Umwelt)
Federal Ministry for Education, Science, Research and Technology
BIH at Charite-Universitaets medizin Berlin
DOI 10.1161/HYPERTENSIONAHA.123.21489
WOS ID 001085239100021
Scopus ID 85174751156
PubMed ID 37675573
Erfassungsdatum 2023-11-28
[➜Korrektur melden]